KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Medpace Holdings (MEDP) over the last 11 years, with Q3 2025 value amounting to $518.1 million.

  • Medpace Holdings' Operating Expenses rose 2305.01% to $518.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 billion, marking a year-over-year increase of 1138.8%. This contributed to the annual value of $1.7 billion for FY2024, which is 730.57% up from last year.
  • As of Q3 2025, Medpace Holdings' Operating Expenses stood at $518.1 million, which was up 2305.01% from $477.0 million recorded in Q2 2025.
  • Medpace Holdings' Operating Expenses' 5-year high stood at $518.1 million during Q3 2025, with a 5-year trough of $212.4 million in Q1 2021.
  • In the last 5 years, Medpace Holdings' Operating Expenses had a median value of $382.5 million in 2023 and averaged $356.7 million.
  • In the last 5 years, Medpace Holdings' Operating Expenses soared by 3487.11% in 2021 and then rose by 3.16% in 2024.
  • Quarter analysis of 5 years shows Medpace Holdings' Operating Expenses stood at $253.7 million in 2021, then grew by 25.22% to $317.7 million in 2022, then grew by 29.41% to $411.1 million in 2023, then grew by 0.03% to $411.2 million in 2024, then increased by 25.99% to $518.1 million in 2025.
  • Its Operating Expenses was $518.1 million in Q3 2025, compared to $477.0 million in Q2 2025 and $445.0 million in Q1 2025.